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SAMJ
Protection of the human research participant: A structured review
1.    The Declaration of Helsinki has been recognised as one of the most 
authoritative statements on ethical standards for human research 
in the world.
2.    The memorandum Permissible Medical Experimentation was a set 
of rules for research on human participants, and later became the 
Nuremburg Code.
3.    The broad South African (SA) Department of Health definition of 
human research includes, but is not limited to, any research that 
contributes to the knowledge of biological or social processes in 
human beings.
4.    The implication of this broad interpretation is that almost all 
health-related or social-science research involves a human 
participant.
Survival of patients with Kaposi’s sarcoma (KS) in the SA 
antiretroviral treatment era: A retrospective cohort study
5.    The start of SA’s antiretroviral therapy programme in 2004 resul-
ted in a shift from symptomatic palliation to potential cure for 
HIV-positive KS patients.
6.    The advent of antiretroviral therapy dramatically decreased KS 
incidence, morbidity and mortality in high-income countries.
Therapeutic drug monitoring of amlodipine and the Z-FHL/
HHL ratio: Adherence tools in patients referred for apparent 
treatment-resistant hypertension
7.    A patient’s usual BP is ‘strongly and directly’ associated with 
cardiovascular and overall mortality, and lowering the BP reduces 
this risk.
8.    A consistent finding is that ~50% of treated patients fail to achieve 
a goal of <140/90 mmHg.
Short-term outcomes of inborn v. outborn very-low-birth-weight 
neonates (<1 500 g) in the neonatal nursery at Groote Schuur 
Hospital, Cape Town, SA
9.    The initial resuscitation and stabilisation of preterm infants after 
delivery affects their morbidity and mortality.
Bibliometric trends of South African environmental health 
articles between 1998 and 2015: Making local research visible  
and retrievable
10.    It is easy to find SA environmental health articles in literature 
searches using ‘environmental health’ as the keyword.
CME
User perspectives on Implanon NXT in SA: A survey of 12 public-
sector facilities
11.    Removals were most common among married and cohabiting 
women.
12.    In the Demographic and Health Survey 2016, ~4% of sexually 
active women in SA were using the implant.
Uptake and early removals of Implanon NXT in SA: Perceptions 
and attitudes of healthcare workers
13.    The SA government introduced Implanon NXT, a long-acting 
subdermal contraceptive implant, in 2014.
14.    Nurses lacked confidence in providing implant services effectively, 
particularly removals, which they ascribed to the brief, cascade-
type training received.
15.    Side-effects, particularly irregular bleeding, are the most common 
reason for early removals.
Gaps in monitoring systems for Implanon NXT services in SA:  
An assessment of 12 facilities in two districts
16.    Implanon NXT offers 3 years of protection against pregnancy.
17.    In the year after the launch of Implanon NXT, the Department 
of Health (DoH) reported that ~800 000 implants had been 
inserted and that >6 000 healthcare providers had been trained 
with regard to implant provision.
18.    The DoH stated that by April 2015, according to their estimates, 
~5 000 removals had been recorded and that this figure has been 
steadily rising over time.
19.    The actual number of and reasons for implant removals are well 
known.
20.    Clinical studies of Implanon NXT showed that complications 
occur in ~1% of insertions.
